More than a decade ago, Lendmark Financial Services CEO Bobby Aiken watched a childhood friend navigate his son Chip's cancer treatment and decided to take action. That commitment became Climb to CURE, which raised an incredible $1.52 million this year to support childhood cancer research. Thanks to the dedication of Lendmark employees, their families, customers, and business partners, Climb to CURE has contributed more than $10 million to CURE since 2015. Every dollar raised supports precision medicine research, which seeks to match each child with the treatments most likely to be effective for their specific cancer. Thank you, Lendmark, for continuing to invest in a future with better treatments, fewer side effects, and more children reaching survivorship. Your partnership is helping change what's possible for kids with cancer and their families. #CUREChildhoodCancer #LendmarkClimbtoCURE #ChildhoodCancerAwareness #ChildhoodCancerResearch #PrecisionMedicine #ChildhoodCancerFamilySupport #CorporateSocialResponsibility #GivingBack #CommunityImpact